Melanin-mimetic
polydopamine nanoparticles (PDA NPs) are emerging
as promising candidates for topical and transdermal drug delivery
because they mimic melanin, a naturally occurring skin pigment. However,
our knowledge of their interactions with human skin remains limited.
Hence, we set out to investigate the role of PDA NP surface chemistry
in modulating their skin deposition. PDA NPs were synthesized by base-catalyzed
oxidative self-polymerization of dopamine and functionalized with
poly(ethylene glycol) (PEG) bearing different termini to obtain neutral,
anionic, cationic, and hydrophobic PEGylated NPs. NPs were characterized
by dynamic light scattering, transmission electron microscopy, Fourier
transform-infrared spectroscopy, and X-ray photoelectron spectroscopy.
The NPs were then labeled with rhodamine B, and their skin interactions
were investigated both in vitro, using a Strat-M membrane, and ex
vivo, using excised whole thickness human skin. In vitro diffusion
studies revealed that the NPs did not permeate transdermally, rather
the NPs accumulated in the Strat-M membrane after 24 h of incubation.
Membrane deposition of the NPs showed a strong dependence on surface
chemistry, with anionic (unmodified and carboxyl-terminated PEGylated)
NPs achieving the highest accumulation, followed by neutral and cationic
NPs, whereas hydrophobic NPs achieved the lowest degree of accumulation.
In ex vivo permeation studies, we observed that surface modification
of PDA NPs with PEG serving as an antifouling coating is essential
to maintaining colloidal stability upon skin contact. Moreover, anionic
PEGylated NPs were able to achieve 78% skin accumulation, which was
significantly higher than neutral and cationic NPs (51 and 34% accumulation,
respectively). Our findings provide important insights into the role
of surface chemistry in enhancing the skin accumulation of melanin-mimetic
PDA NPs as potential sunscreens and carriers for skin-targeted treatments.